REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 448 filers reported holding REPLIGEN CORP in Q1 2022. The put-call ratio across all filers is 1.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,707 | +35.3% | 10,733 | +20.3% | 0.01% | +42.9% |
| Q2 2023 | $1,262 | -13.1% | 8,923 | +3.5% | 0.01% | -12.5% |
| Q1 2023 | $1,452 | -0.5% | 8,623 | 0.0% | 0.01% | -11.1% |
| Q4 2022 | $1,460 | -99.9% | 8,623 | 0.0% | 0.01% | -18.2% |
| Q3 2022 | $1,613,000 | +15.2% | 8,623 | 0.0% | 0.01% | +22.2% |
| Q2 2022 | $1,400,000 | -6.0% | 8,623 | +8.8% | 0.01% | +12.5% |
| Q1 2022 | $1,490,000 | -34.8% | 7,923 | -8.1% | 0.01% | -27.3% |
| Q4 2021 | $2,284,000 | -14.3% | 8,623 | -6.5% | 0.01% | -21.4% |
| Q3 2021 | $2,665,000 | +44.8% | 9,223 | 0.0% | 0.01% | +40.0% |
| Q2 2021 | $1,841,000 | +2.7% | 9,223 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $1,793,000 | +1.5% | 9,223 | 0.0% | 0.01% | -9.1% |
| Q4 2020 | $1,767,000 | +43.9% | 9,223 | +10.8% | 0.01% | +22.2% |
| Q3 2020 | $1,228,000 | -40.3% | 8,323 | -50.0% | 0.01% | 0.0% |
| Q2 2020 | $2,058,000 | – | 16,646 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |